跳至主要内容
临床试验/NCT04755855
NCT04755855招募中不适用

Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
200
试验地点
1
主要终点
Oncologic outcomes as measured by overall survival, disease specific survival and recurrence free survival

研究概览

简要总结

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Days 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
  • Patients with a diagnosis of sinonasal cancer
  • Patients undergoing treatment at Mayo Clinic

排除标准

  • Healthy individuals
  • Unwilling to sign the informed consent

结局指标

主要结局

Oncologic outcomes as measured by overall survival, disease specific survival and recurrence free survival

时间窗: Through study completion, an average of 5 years

次要结局

  • Describe the molecular foundation of sinonasal malignancies utilizing RNA sequencing to identify transcriptomic tumor profiles(Through study completion, an average of 5 years)
  • Quality of life outcomes including the University of Washington Quality of Life Questionnaire (UW-QOL v4) and the Sinonasal Outcome Test 22 (SNOT22)(Through study completion, an average of 5 years)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jacob G. Eide, MD

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验